VMBIP Newsletter, September 5, 2008

VMBIP Updates

•	VACMAN 4.1.4.1 deployment began this morning, September 5.  This version of VACMAN gives you the ability to order pediatric Td (NDCs 49281-0291-10 and 49281-0291-83) and pediatric DT at less than the minimum order size.   Please remember to periodically download from CDC, even when you are not placing an order, to ensure you have the latest VACMAN status updates. 
•	For grantees serviced by the Memphis distribution center only:  McKesson has identified a technical issue related to an upgrade to its warehouse management system that has caused some split shipments.  The issue was corrected yesterday (September 4), but may affect orders that get processed through COB September 5.  If you have any questions, please contact McKesson Specialty Customer Care.
•	On September 9 and 10, 2008, the VTrckS Grantee Advisory Committee (GAC) is scheduled to have its first face-to-face meeting in Atlanta.  As you know, the mission of the GAC is to ensure immunization program needs are well represented during all phases of development until VTrckS goes live.  This meeting will provide a high level VMBIP Overview (preparation for VTrckS) and a prototype demonstration.  If you have specific questions, comments or suggestions, please contact any GAC member to bring these issues forward.  A list of members and their contact information is on the VMBIP website, VTrckS page.  
•	Data Warehouse Report Status:
o	Nonviable Vaccine Report - CDC is conducting internal meetings to further define requirements around the data needed to support a more comprehensive report which contains more detailed return codes and data.  The current report will remain the same until all the new requirements and data can be put in place to support the report.  We appreciate your patience as we move to develop a better report to help support your vaccine program.
o	Grantee Specific Inventory Report - we are currently working with McKesson to review the data utilized to support the report and will send future updates as soon as a solution is in place to ensure the data behind the reports are accurate.

VMBIP Performance Dashboard
Weekly Performance Metric Scorecard
    
A.
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 8-15-08:  89.2 percent
Week Ending 8-22-08:  88.7 percent
Week Ending 8-29-08:  89.9 percent
Weighted Average Last 3 Weeks:  89.2 percent
Explanation:  None

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 8-15-08:  100 percent
Week Ending 8-22-08:  99.0 percent
Week Ending 8-29-08:  98.9 percent
Weighted Average Last 3 Weeks:  99.2 percent
Explanation:  none

C1
Metric: 99 percent Order Quality (McKesson Responsibility)
Week Ending 8-15-08:  100 percent
Week Ending 8-22-08:  99.99 percent
Week Ending 8-29-08:  100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  none

C2
Metric: 99 percent Order Quality (All Responsibility – all error types)
Week Ending 8-15-08:  97.94 percent
Week Ending 8-22-08:  99.33 percent

Week Ending 8-29-08:  99.98 percent
Weighted Average Last 3 Weeks:  99.14 percent
Explanation:  none

D
Metric: 99.75 percent – Cold Chain Quality
Week Ending 8-15-08:  100 percent
Week Ending 8-22-08:  100 percent
Week Ending 8-29-08:  100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  none

E
Metric: Vaccine Receipt and Put Away and CDC Transmission
Week Ending 8-15-08:  100 percent
Week Ending 8-22-08:  100 percent
Week Ending 8-29-08:  100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  None

F
Metric: State Funded PO Transmission
Week Ending 8-15-08:  100 percent
Week Ending 8-22-08:  100 percent
Week Ending 8-29-08:  100 percent
Weighted Average Last 3 Weeks:  100 percent
Explanation:  None.

A. Percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation)  - an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		

B. Percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation)	

C1. Percent of provider orders delivered with viable vaccine; excludes errors that aren't McKesson's responsibility – Return Reasons: Temp Monitor, non-compliant pack-out, mis-ship, undeliverable/customer not available, or carrier damage

C2. Percent of provider orders delivered with viable vaccine; includes all errors for both CDC and McKesson: Return Reasons: see C1 for McKesson responsibility reasons and incorrect address/delivery info, site damaged, expired product, product recall, and other are CDC’s responsibility 

D.  Percent of provider orders delivered with cold chain maintained – Return Reason: Temp Monitor	

E.  Percent of CDC replenishment orders McKesson receives into inventory, receives into IT system, and transmits to CDC within 24 (flu) / 48 (other) hrs of delivery by manufacturer	

F.  Percent of grantee replenishment orders McKesson faxes/e-mails receipt to grantees within 48 hrs of delivery by manufacturer
 
Vaccines on allocation HIB and FLU; Vaccines on manufacturer shortage Merck Hep A
Vaccines placed on backorder during the most recent week: DTAPHBIP (2,245 doses) inventory received next day, orders released; DTAPIPV (460 doses) – new product inventory ordered; Hep A (15,965) – inventory received next day, orders released; Hep A – Adult (70 doses) - inventory received next day, orders released; Pneumo (2,400 doses) – inventory ordered not yet received; TD (70 doses) – long-dated vaccine not available from manufacturer; TDAP (3,130 doses) – vaccine arrived and backorders were released the next day 

VMBIP Performance Dashboard – Shipping Metrics by Distribution Center
Weekly Performance Metric Scorecard 

Memphis (8578)
A.
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 8-15-08:  84.2 percent
Week Ending 8-22-08:  84.4 percent
Week Ending 8-29-08:  86.7 percent
Weighted Average Last 3 Weeks:  85.1 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 8-15-08:  100 percent
Week Ending 8-22-08:  98.5 percent
Week Ending 8-29-08:  98.5 percent
Weighted Average Last 3 Weeks:  99.0 percent
Explanation:  none

Sacramento (8576)
A
Metric: 80 percent – 3 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders)
Week Ending 8-15-08:  98.9 percent
Week Ending 8-22-08:  99.3 percent
Week Ending 8-29-08:  99.8 percent
Weighted Average Last 3 Weeks:  99.3 percent
Explanation:  none

B.
Metric: 100 percent – 5 Day Shipments (Orders without Backorder Lines or Allocated Vaccine Orders
Week Ending 8-15-08:  100 percent
Week Ending 8-22-08:  100 percent
Week Ending 8-29-08:  99.9 percent
Weighted Average Last 3 Weeks: 100 percent
Explanation:  none
A. Percent of provider orders shipped within 3 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation) -  an order is defined as all vaccines requested by a provider on a given day; a line (order line) is defined as the individual vaccines that make up the order		

B. Percent of provider orders shipped within 5 days of McKesson receiving order from CDC; removes all lines of product on backorder (backorders or over-allocation)

As a reminder, VMBIP related all-grantee messages are posted to the VMBIP website at: http//www.cdc.gov/vaccines/programs/vmbip/documents.htm and previous newsletters are posted at http//www.cdc.gov/vaccines/programs/vmbip/newsletters.htm 

If you have any questions or comments about the contents of this email, please contact Brad Prescott bap3@cdc.gov or Julie Orta jio7@cdc.gov, with a cc to your project officer. 

Brad Prescott
Project Lead
Vaccine Management Business Improvement Project 
Immunization Services Division 
Centers for Disease Control and Prevention
404-639-8796 (direct)
404-639-8627 (fax)
bap3@cdc.gov

This document can be found on the CDC website at:
http://www.cdc.gov/vaccines/programs/vmbip/downloads/newsletters/vmbip-nl-09-05-08.rtf